 Connection
Marc Bonaca to Risk Reduction Behavior
This is a "connection" page, showing publications Marc Bonaca has written about Risk Reduction Behavior.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.082 |
|
|
|
-
Galli M, Abbate A, Bonaca MP, Crea F, Forte M, Frati G, Gaudino M, Gibson CM, Gorog DA, Mehran R, Montone RA, O'Donoghue ML, Steg PG, Sciarretta S, Angiolillo DJ. Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies. Nat Rev Cardiol. 2026 Jul; 23(7):500-523.
Score: 0.051
-
Scirica BM, Bohula EA, Dwyer JP, Qamar A, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Murphy SA, Im K, Leiter LA, Gupta M, Patel T, Miao W, Perdomo C, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD. Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial. Circulation. 2019 01 15; 139(3):366-375.
Score: 0.031
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|